Multani Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 25-05-2024
- Paid Up Capital ₹ 2.16 Cr
as on 25-05-2024
- Company Age 38 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.70 Cr
as on 25-05-2024
- Satisfied Charges ₹ 22.66 Cr
as on 25-05-2024
- Revenue 9.26%
(FY 2023)
- Profit -8.93%
(FY 2023)
- Ebitda -2.87%
(FY 2023)
- Net Worth 25.25%
(FY 2023)
- Total Assets 5.35%
(FY 2023)
About Multani Pharmaceuticals
The Corporate was formerly known as Multani Pharmaceuticals P Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 2.16 Cr.
The company currently has active open charges totaling ₹25.70 Cr. The company has closed loans amounting to ₹22.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Multani, Rajesh Sabharwal, Sanjay Kumar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230DL1986PLC023539
- Company No.
023539
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Mar 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Multani Pharmaceuticals Limited offer?
Multani Pharmaceuticals Limited offers a wide range of products and services, including Diabetic Medicines, Ayurvedic Medicines, Sexual Wellness, Men Performance Enhancers, Health Conditions, Mental Wellness, Pain Relief, Immunity Boosters, Chyawanprasha, Popular Category.
Who are the key members and board of directors at Multani Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogesh Sahni  | Director | 27-Feb-2019 | Current |
| Pradeep Multani | Director | 08-Mar-1986 | Current |
| Rajesh Sabharwal | Director | 27-Feb-2019 | Current |
| Sanjay Kumar | Director | 01-Feb-2023 | Current |
| Vinay Rungta | Director | 01-Feb-2023 | Current |
Financial Performance and Corporate Structure Insights of Multani Pharmaceuticals.
Multani Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.26% increase. The company also saw a slight decrease in profitability, with a 8.93% decrease in profit. The company's net worth Soared by an impressive increase of 25.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Multani Pharmaceuticals?
In 2023, Multani Pharmaceuticals had a promoter holding of 100.00%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Multani Properties And Investment Co Pvt LtdActive 48 years 6 monthsPradeep Multani is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Jan 2024 | ₹1.10 Cr | Open |
Sidbi Creation Date: 18 Jan 2021 | ₹1.50 Cr | Open |
Others Creation Date: 31 Dec 2002 | ₹23.10 Cr | Open |
How Many Employees Work at Multani Pharmaceuticals?
Multani Pharmaceuticals has a workforce of 432 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Multani Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Multani Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
